1. medicine logistics mode

Pharmaceutical logistics relies on certain logistics equipment, information technology and marketing management systems to effectively integrate the upstream and downstream resources in the drug production and sales network, and improve order processing capabilities by optimizing the acceptance, storage, sorting, and distribution of drug supply and marketing links., Reduce inventory and shorten delivery time, reduce circulation costs, improve service levels and capital use efficiency, and realize automation, informatization and efficiency. In the pharmaceutical logistics industry chain, it mainly involves industry supply enterprises, pharmaceutical logistics enterprises and pharmaceutical consumption terminals. The upstream link mainly includes drug production and commercial enterprises; the middle link is the circulation link of drugs, mainly drug logistics enterprises, which can be divided into internal subsidiaries affiliated to drug groups and third-party logistics enterprises; pharmaceutical consumption terminals refer to drug users, mainly including hospitals at all levels, primary medical institutions, retail pharmacies and so on.

Pharmaceutical logistics mode can be divided into three types: terminal hospital-oriented, commercial enterprise-oriented and third-party logistics-oriented.. Terminal hospital-led refers to the terminal hospital directly with the production enterprises or commercial enterprises to sign procurement contracts, and by itself or entrust third-party logistics enterprises to carry out distribution services. This model can reduce intermediate links, reduce costs and improve efficiency, but it also requires hospitals to have strong procurement capabilities and logistics management capabilities. The commercial enterprise-led type refers to the commercial enterprise as an intermediary, between the production enterprise and the terminal hospital for the transfer of goods rights, and to provide distribution services. This model can take advantage of the scale advantages and professional capabilities of commercial enterprises to improve service levels and market share, but it will also increase intermediate links and increase costs. The leading type of third-party logistics refers to the distribution service in which professional third-party logistics enterprises act as service providers and carry out the transfer of goods rights between production enterprises and terminal hospitals. This model can give full play to the professional and technical advantages of third-party logistics companies, and provide customized and diversified services, but it also requires third-party logistics companies to have strong financial strength and risk-taking capabilities.

2. pharmaceutical logistics industry competition pattern

Domestic pharmaceutical logistics enterprises are mainly divided into pharmaceutical enterprise logistics subsidiaries, pharmaceutical business enterprise logistics subsidiaries, professional third-party pharmaceutical logistics enterprises and other social logistics enterprises. The implementation of the "two-invoice system" for medicine (I. e., pharmaceutical production enterprises issue one invoice to circulation enterprises and pharmaceutical circulation enterprises issue one invoice to medical institutions to compress circulation links) has shortened the pharmaceutical supply chain chain. The combination of pharmaceutical production, pharmaceutical circulation and terminal on the chain nodes is closer, large-scale production enterprises have stronger advantages, some traditional circulation and distribution enterprises have transformed into supply chain service providers, and the agglomeration effect of industrial parks is more obvious, the efficiency of drug distribution has been greatly improved, the level of medical services has been improved, the trend of supply chain flattening is significant, and the development trend of pharmaceutical logistics is decentralized.。

At present, China's pharmaceutical logistics enterprises have basically formed three major gradients: radiation throughout the country, radiation parts of provinces and cities, and radiation single provinces and cities. Among them, the logistics and distribution networks of Shanghai Pharmaceutical, China Resources Pharmaceutical, Sinopharm Holdings, Ruikang Pharmaceutical and Jiuzhoutong basically radiate most parts of the country, with obvious competitive advantages in the industry.. According to data from the Champ Consulting Group,2022The scale of China's pharmaceutical logistics market reached2795.3Billion yuan, of which the market share of the five leading enterprises is close60%. The five leading companies are China Pharmaceuticals, Shanghai Pharmaceuticals, China Resources Pharmaceuticals, Kyushu Tong and Sinopharm Holdings.

3. Pharmaceutical Logistics Market Demand and Forecast

With the gradual implementation of major pharmaceutical reforms such as the "two-invoice system", tax reform, and consistency evaluation, the state has paid more and more attention to the standardization and scale of the pharmaceutical logistics industry, and has continuously introduced policies to increase supervision and promote the development of the industry; The development of the circulation industry has also put forward more demands on the pharmaceutical logistics industry, and the pharmaceutical logistics industry is in a stage of continuous growth. According to data from the Champ Consulting Group,2021The total amount of pharmaceutical logistics in China in2795.1billion yuan,2022The total amount of China's pharmaceutical logistics in2988.3Billions of dollars, expected2023The total amount of pharmaceutical logistics in China will reach3195.7Billions of dollars.

Development Trend of 4. Pharmaceutical Logistics Industry

The development trend of pharmaceutical logistics industry is mainly reflected in the following aspects:

（1) The level of informatization has been continuously improved. With the wide application of Internet, Internet of things, big data, cloud computing and other technologies, the informatization level of pharmaceutical logistics industry has been continuously improved, which has realized the traceability, monitoring and scheduling of drugs, and improved the safety and quality of drugs. At the same time, informatization has also promoted the supply chain coordination of the pharmaceutical logistics industry, realized the information sharing and resource integration of upstream and downstream enterprises, and improved the efficiency and efficiency of the supply chain.

（2) The smart logistics model is gradually maturing. Intelligent logistics refers to the use of artificial intelligence, machine learning, blockchain and other technologies to realize the automation, intelligence and optimization of pharmaceutical logistics through intelligent equipment, intelligent warehousing, intelligent distribution and other ways. The smart logistics model can reduce labor costs, improve operational efficiency, enhance service quality, and meet the individual needs of customers.

（3) The concept of green logistics is getting deeper and deeper. Green logistics refers to the process of pharmaceutical logistics, as far as possible to reduce environmental pollution and resource consumption, to achieve the sustainable development of pharmaceutical logistics. The concept of green logistics is getting deeper and deeper, which is mainly reflected in the following aspects: one is to use environmentally friendly materials and packaging methods to reduce waste generation; the other is to optimize transportation routes and methods to reduce energy consumption and emissions; the third is to promote recycling and recycling Use to improve resource utilization.

（4) Cross-border pharmaceutical e-commerce is developing rapidly. Cross-border pharmaceutical e-commerce refers to the online sales and distribution of pharmaceutical products across borders or regions through the Internet platform. The rapid development of cross-border pharmaceutical e-commerce mainly benefits from the following factors: first, the support and guidance of national policies, which provides legal protection and tax concessions for cross-border pharmaceutical e-commerce; second, the diversification and personalization of consumer demand, which provides market space and potential for cross-border pharmaceutical e-commerce; third, the promotion and drive of technological innovation, It provides technical support and service guarantee for cross-border pharmaceutical e-commerce.

5. Suggestions and Prospects

As an indispensable part of China's pharmaceutical industry chain, the pharmaceutical logistics industry is of great significance to ensure the health and safety of our people. Facing the complex and changeable market environment and increasing customer demand, pharmaceutical logistics enterprises should seize the opportunity, meet the challenge, continue to innovate and develop, and enhance their competitiveness. Specifically, it is recommended to proceed from the following aspects:

（11) Strengthen standardized management and improve industry standards. Pharmaceutical logistics involves people's life and health issues, and must strictly abide by relevant laws, regulations and standards to ensure that drugs are not affected by pollution, deterioration, and damage during transportation, storage, and distribution. At the same time, it is necessary to continuously improve and improve the standard system of the pharmaceutical logistics industry, establish a unified quality supervision and evaluation mechanism, and improve the reputation and image of the industry.

（2) Accelerate informatization construction and improve operational efficiency. Information is the core competitiveness of the pharmaceutical logistics industry, pharmaceutical logistics enterprises should speed up the construction of information technology, the use of advanced technology, to achieve the whole process of drug visualization, traceability, control, improve the safety and quality of drugs. At the same time, it is also necessary to strengthen information exchange and coordination with upstream and downstream enterprises, realize the optimization and integration of supply chain, and improve operational efficiency and efficiency.

（3) Increase investment in innovation and improve service levels. Innovation is the soul of the pharmaceutical logistics industry, pharmaceutical logistics enterprises should increase investment in innovation, develop new products and services to meet the diverse and personalized needs of customers. At the same time, we should also learn from the advanced experience and models at home and abroad, promote intelligent logistics, green logistics, cross-border pharmaceutical e-commerce and other emerging fields, and improve the service level and market share.

（4) Strengthen personnel training and improve core competitiveness. Talents are the foundation of the pharmaceutical logistics industry. Pharmaceutical logistics enterprises should strengthen personnel training, introduce and cultivate a group of pharmaceutical logistics talents with professional knowledge, skills and quality, and improve their core competitiveness. At the same time, it is also necessary to establish a sound incentive mechanism and guarantee mechanism to stimulate the enthusiasm and creativity of talents and promote the growth and development of talents.

In short, the pharmaceutical logistics industry is an industry full of opportunities and challenges. Shangpu Consulting believes that in the next few years, the pharmaceutical logistics industry will maintain a steady growth trend, and show the characteristics of diversification, intelligence, greening, and internationalization. According to data from the Champ Consulting Group, it is expected2028The size of China's pharmaceutical logistics market will reach5000About 100 million yuan. Pharmaceutical logistics enterprises should seize the development opportunities, meet the market challenges, constantly innovate and make contributions to the healthy development of China's pharmaceutical industry chain.